Cannabis' Impact on Alcohol Consumption

NCT05389930 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2024-08-06

No results posted yet for this study

Summary

This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo.

The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.

Conditions

Interventions

DRUG

THC-dominant cannabis

Smoked cannabis with 9.53% THC and 0.09% CBD

DRUG

CBD-dominant cannabis

Smoked cannabis with 0.35% THC and 11.27% CBD

DRUG

Cannabis placebo

Smoked placebo cannabis plant material

DRUG

Alcohol

Drink containing 0.3 g/kg of alcohol

DRUG

Alcohol placebo

Placebo beverage contains only juice and a negligible trace of alcohol for masking

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • Brown University

    lead OTHER

Principal Investigators

  • Jane Metrik, PhD · Brown University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-16
Primary Completion
2027-03-31
Completion
2027-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389930 on ClinicalTrials.gov